All In Biotech

Drug Trial Radar · NCT07777276

Sleep Quality - Comparing the Effect of Ondansetron or Dexamethasone Given as Routine Prophylaxis Intraoperatively to Prevent Post Operative Nausea and Vomiting (SCORPION)

Sleep Quality - Comparing the Effect of Ondansetron or Dexamethasone Given as Routine Prophylaxis Intraoperatively to Prevent Post Operative Nausea and Vomiting

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Aug 3, 2026

Primary completion

Aug 17, 2029

Study completion Aug 17, 2029

Sponsor

Lead sponsor
Telethon Kids InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Sao Paulo General Hospital; Santa Casa de Misericórdia de Ribeirão Preto; Child and Adolescent Health Service - Perth
First posted
Aug 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 2 years, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Nausea and vomiting are common complications after anaesthesia, and anaesthetists routinely give medications to prevent them. Dexamethasone and ondansetron are the two most commonly used agents and have a long safety record. However, their effects on sleep, behaviour, and overall recovery are not well studied. Understanding these will guide future care. The aim of this study is to determine if dexamethasone or ondansetron given during an anaesthetic affect post-operative sleep, behaviour and recovery in children. Patients enrolled in the study will be randomised to receive either dexamethasone or ondansetron during their procedure. This randomisation will be blinded to patients, their families and their treating anaesthetist. Information about the patient's pain, recovery and sleep will be collected over 7 days post-operatively using online surveys. A subset of patients will also be asked to complete additional pre-operative non-invasive monitoring using an oximeter and an actigraph to measure their sleep quality before and after surgery. In addition to the postoperative surveys, these patients will be asked to wear the oximeter and actigraph for 3 nights before and immediatey after surgery. Patients who are admitted overnight postoperatively will also have additional transcutaneous carbon dioxide monitoring on the night of their surgery.

Conditions

  • Postoperative Sleep Quality
  • Postoperative Behaviour
  • Postoperative Recovery in Children
  • Postoperative Nausea and Vomiting (PONV)
  • Paediatric Surgery
  • Anaesthesia

Interventions

  • Dexamethasone (IV)Drug

    Dexamethasone (0.2 mg/kg, maximum 8 mg) will be diluted to 2mL with normal saline and administered intravenously at the start of procedure.

  • Ondansetron ivDrug

    Ondansetron (0.15mg/kg, maximum 4mg) will be diluted to 2mL with normal saline and administered intravenously 15-30 minutes before the end of surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Compare parent-reported sleep quality on day 1 post-op between children receiving intravenous dexamethasone and children receiving intravenous ondansetron during their anaesthetic.Time frame: Sleep quality will be assessed on day 1 post-surgery

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Perth Children's Hospital

    Perth, Western Australia, Australia · Recruiting

  • Hospital das Clinicas

    São Paulo, São Paulo, Brazil · Recruiting

  • Santa Casa de Misericórdia de Ribeirão Preto

    São Paulo, São Paulo, Brazil · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.